# FDA approves Replimune melanoma drug previously rejected twice

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-07 10:29 UTC · Category: Business · Sources: 9 · Current Velocity: 8.25

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Barron's | Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. | 2026-08-06 20:46 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxNamVMXzZ1LW5WMjBnVXAyRTZBVFpGZVppUkRjRHhHX0dlZGNMdWVCcEVIVElEX012NzN6OWhXaVFYbm5OdjlTYTA4c25tbHZGaUd5ODNiUFdGZnQ0cG1taWtXV2xzbGszTjRNREE3SVlnOXh5Sm9EaFVSeEIxSjBGUk9Tdmc?oc=5) |
| STAT | Pharmalittle: We're reading about Replimune's melanoma drug, a Medicare policy change, and more | 2026-08-06 20:46 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxPYVgyWkNmZHc0eTJMN3JwMC1WYWNfaEk5WWRtRl84M3VBNXlpU3dNS2hMZTU3ZThXQ3dBSFowYnp6Z3ZSQ0l1cEtpTjFqc1ljV3BERlZKVFRKSU9SZlZYYzR4cEstSkFHOW5DTUwzcDVRbW5KdDJJZ0RKcHRoWEVBaEMxdy1IV0NYRUhxR1QzTE0yeFFpSUw1dg?oc=5) |
| BioPharma Dive | Replimune rebounds to win FDA approval of melanoma drug | 2026-08-06 20:46 | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxPb1YzVGxJSGFMTzl6TGxLbjgzbS1ONHVKSjFHUjJjQVRkU3llVFE5MDduRUlCMmY3MVZTOFFJbVg0azVjWFhfdW4zYi1lNUFhRHpYUG9pXzYyeGlsR210LVlaZmF6RjZqdGZzcENVUHYxQk9ELXBTVzMxb3BIeVdUSHljMC1zYUNsZ2NwWWpuYw?oc=5) |
| qz.com | FDA approves Replimune's Tudriqev melanoma drug on third try | 2026-08-06 20:46 | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxPcktvRzU1bzE5djhaQmpoelJxalpydVk1SkdJYmJubC0xSEN0c0FwQ0R4WVNIQlFUcXFPVFM1bkgxdUViWXNuaG40UUJGOWQtXzdmZndQNkg1RldjMmFiZHQxZEJrNjgzQ2c4Mk44ajBXSXJ0MzBLbEtfazV3WDVaWk9n?oc=5) |
| Endpoints News | Replimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections | 2026-08-06 20:46 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOYloxZjZQYnVRMUljdnNBZVZ2VUlqck1abGwwWFhuUWYyc0FtR0ExSHFRUXdCa3JaR1VQaVFmNEowOGtQd1VXZjkyQU5jam94cWRueU5naUpxLVZ4R2U2eHNmYXRnSHNjbTdBaHA5aWVYRTgyMDBlUzkxclpzTzBNY0hTaE4zS2N4Xzd3NFJDLUpCZW9f?oc=5) |
| Yahoo Finance | REPL Stock Slumps 11% After-Hours | 2026-08-06 20:04 | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxOSmpPWS1MN21ubDF6X0U1Z1ZwUjllaGVnTU9XZWs5OUNFMnprOEpzenJOcU9QNGtHa1dMRDRzV3lzSjQ4X3VrN0swbGVncGZpYXF3R1FPTnV1MWFJMWtlS0JhSTVzV3V0QkNRQ2NWRlRuZE9GREh2TTMwNk5PZFpBZXR0cUduaF9XQXQ0S2x2R0M?oc=5) |
| Yahoo Finance | Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen | 2026-08-06 20:04 | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdEV0dGxDYTN3VzNMeXhvZk1LejJhNGFYc05TS2JjdXo2dGFGLVVpNVpGT1FKWTlqdmNMbEctOUEtR0xRd0NjWnhkUThQeEJPSHFuVXBUN1VSVW4wNEJCMzBpT3YtSWlNeXk2alQtVHpIZzNCZTY5OGpOanNwYjE4RG1FMjNZeFNPbUFaRDZwcUdna1hVYjFqOEkwWE45VWt5TGkzQ0FHc0g?oc=5) |
| Reuters | US FDA approves Replimune's skin cancer drug after prior rejections | 2026-08-06 20:04 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxQSzRDTVZPLXhNYTNDWDYyVXZTemQwOXJNQVlVblBvZHVpbUxPX0dQQzVRVTJIT2h5ZmFjVGlOZjNScjRPT1FveDliRmtNdEh5WEtNWUF4Sk5xVi1qdV9aQ3A3eEZvWHNGUDFCWGNhT0ZEb2gwdWw1amRPWkJ2d1M4em1VVVZCdUM3YW9JLXhMamVWOUFseVZnNTd3OWFwaFdWdy1VNVlITVVqUWR6dFYzZ0xFRzlGZw?oc=5) |
| Fierce Pharma | Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle | 2026-08-06 20:04 | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxPMnRWNF9XVk82X2tYdkhkM0NjVGNaN3N5VlMwVm9fZDI3UTNiV3ZMMWhFbC1rYkRKWHRuSUxyT3JXZlhVYWpCbUJwMDNYYUI1X3Y2MFVHNFczUnBfM2NHeDhKa3plNXFQUVI3TENlZnZIWFVNc1g1RjVUMFZqUzc2SFI1UWQwMkc5QU5CQzBQa1VEOHRSX3B4TE1faXJIaXh6d1VPTmtwWXdGRGQ1SFJZbWx0TFNwRUJwcnNmVUdB?oc=5) |
| WSJ | FDA Approves Replimune’s Melanoma Drug on Third Attempt | 2026-08-06 20:04 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxPRmRrSHFJX3AwbEdBc2pUd0E0TVFmVmNzNWtNNVZSMnBSQWx6cDRZOF85bEcybzN6MlJKTmNHRlN2OVdGZlphSEtrdHRjY0ZPX1M5QTEtb0l1MEdla2NscW55Tkt1elFmVURTdTZ4S2l6Ymc3SWpwcHAxYUdsYnhTRi02VVlVVE9LWkJzOHV3TGFzU1JuTVd3TlZkaTI?oc=5) |
| STAT | FDA approves Replimune melanoma drug previously rejected twice | 2026-08-06 20:04 | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxOOHAwUEhWcjlRVHE5UEVBekM0RXVPMW1RY2g0UHNyZjE0bjlaVmQxcUJWMkJOZ2huTUU1amo5RThNSV94R1Z2Q2JxR0xBSXJEWGZaNnA1OF82SHBDc3RhUUJhQmliaWJBaUpHVmJ2TXJ0bVBheURqQ3VSV0N2d1hIY1dhQ0JWUDl1VHE5SHBMUnJBbTB6RDZVWTJvQmpaLTR0bkNoV2ZOUQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-07/fda-approves-replimune-melanoma-drug-previously-rejected-twice*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*